Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 5/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12189840 | 0.86 | PPARG (0.60) | HTTMAPTLMNAALOX12SMN1; SMN2 | |
| SCHEMBL3299728 | 0.86 | PPARG (0.60) | HTTMAPTLMNAALOX12SMN1; SMN2 | |
| SCHEMBL3299127 | 0.86 | PPARG (0.60) | HTTMAPTLMNAALOX12SMN1; SMN2 | |
| SCHEMBL3299123 | 0.86 | PPARG (0.60) | HTTMAPTLMNAALOX12SMN1; SMN2 | |
| SCHEMBL13324898 | 0.81 | PPARG (0.62) | HTTMAPTLMNAMEN1KMT2A | |
| SCHEMBL13359395 | 0.81 | PPARG (0.62) | HTTMAPTLMNAMEN1KMT2A | |
| SCHEMBL13359378 | 0.81 | CHRM1 (0.60) | HTTMEN1KMT2AGAATDP1 | |
| SCHEMBL13324881 | 0.81 | CHRM1 (0.60) | HTTMEN1KMT2AGAATDP1 | |
| SCHEMBL16502054 | 0.77 | PPARG (0.57) | HTTMAPTLMNAMEN1KMT2A | |
| SCHEMBL13359396 | 0.77 | PPARG (0.57) | HTTMAPTLMNASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160075636-A1 | Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester | CYMABAY THERAPEUTICS, INC. (US) | 2016-03-17 | — | — | US | disclosed |
| US-20120232302-A1 | Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester | METABOLEX, INC. | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075636-A1 | Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester | PC, ACACA, ACACB | HTT 1387/4885MAPT 2708/4885LMNA 2514/4885 |
| US-20120232302-A1 | Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester | PC, ACACA, ACACB | HTT 1387/4885MAPT 2708/4885LMNA 2514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.